Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CDC25A | P30304 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | PTAFR | P25105 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.41 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphocholine SCHEMBL28111186 | 0.89 | TSHR (0.54) | TSHRLMNAESR1ADORA3CDC25A | |
| SCHEMBL368310 | 0.88 | LMNA (0.56) | TSHRLMNAESR1ADORA3CDC25A | |
| SCHEMBL28329138 | 0.87 | TSHR (0.51) | TSHRLMNAESR1ADORA3CDC25A | |
| Phosphocholine SCHEMBL14738989 | 0.86 | GALR3 (0.41) | TSHRLMNAESR1ADORA3CDC25A | |
| SCHEMBL27910406 | 0.86 | TSHR (0.50) | TSHRLMNAESR1ADORA3CDC25A | |
| Phosphocholine SCHEMBL12979922 | 0.85 | SMN1; SMN2 (0.45) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL6462016 | 0.85 | THRB (0.45) | TSHRLMNAESR1ADORA3CDC25A | |
| Water SCHEMBL28109847 | 0.85 | TSHR (0.49) | TSHRLMNAESR1ADORA3CDC25A | |
| Hydrochloric Acid SCHEMBL6114873 | 0.84 | TSHR (0.66) | TSHRLMNAADRA1AMAPTSMN1; SMN2 | |
| SCHEMBL3923049 | 0.84 | LMNA (0.64) | TSHRLMNAESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343529-B2 | Implantable drug delivery devices having alternating hydrophilic and amphiphillic polymer layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-01-01 | — | — | US | claimed |
| US-20120225303-A1 | Implantable Drug Delivery Devices Having Alternating Hydrophilic And Amphiphilic Polymer Layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-09-06 | — | — | US | claimed |
| US-8202529-B2 | Implantable drug delivery devices having alternating hydrophilic and amphiphilic polymer layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-06-19 | — | — | US | claimed |
| US-20110137243-A1 | Coating On A Balloon Device | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-06-09 | — | — | US | claimed |
| WO-2009148777-A2 | IMPLANTABLE DRUG DELIVERY DEVICES HAVING ALTERNATING HYDROPHILIC AND AMPHIPHILIC POLYMER LAYERS | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2009-12-10 | — | — | WO | claimed |
| US-20090297575-A1 | Implantable Drug Delivery Devices Having Alternating Hyrdrophilic And Amphiphilic Polymer Layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2009-12-03 | — | — | US | claimed |
| EP-4051778-A1 | METHODS AND COMPOSITIONS FOR ASSEMBLY OF BIOLOGICAL NANOPORES | Stratos Genomics Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| WO-2021087118-A1 | METHODS AND COMPOSITIONS FOR ASSEMBLY OF BIOLOGICAL NANOPORES | STRATOS GENOMICS, INC. (US) | 2021-05-06 | — | — | WO | disclosed |
| EP-3334840-A1 | SINGLE MOLECULE NUCLEIC ACID SEQUENCING WITH MOLECULAR SENSOR COMPLEXES | Stratos Genomics, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| US-20180044725-A1 | POLYNUCLEOTIDE BINDING PROTEIN SEQUENCING | Roche Sequencing Solutions, Inc. | 2018-02-15 | — | — | US | disclosed |
| EP-3265589-A1 | POLYNUCLEOTIDE BINDING PROTEIN SEQUENCING CROSS REFERENCE TO RELATED APPLICATIONS | Stratos Genomics, Inc. (US) | 2018-01-10 | — | — | EP | disclosed |
| US-20170159115-A1 | SINGLE MOLECULE NUCLEIC ACID SEQUENCING WITH MOLECULAR SENSOR COMPLEXES | Roche Sequencing Solutions, Inc. | 2017-06-08 | — | — | US | disclosed |
| WO-2017027518-A1 | SINGLE MOLECULE NUCLEIC ACID SEQUENCING WITH MOLECULAR SENSOR COMPLEXES | STRATOS GENOMICS, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
| US-8343529-B2 | Implantable drug delivery devices having alternating hydrophilic and amphiphillic polymer layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-20120225303-A1 | Implantable Drug Delivery Devices Having Alternating Hydrophilic And Amphiphilic Polymer Layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-09-06 | — | — | US | disclosed |
| US-8202529-B2 | Implantable drug delivery devices having alternating hydrophilic and amphiphilic polymer layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-20110137243-A1 | Coating On A Balloon Device | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-20110129514-A1 | Hygroscopic coating on a balloon device | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2011-06-02 | — | — | US | disclosed |
| WO-2009148777-A2 | IMPLANTABLE DRUG DELIVERY DEVICES HAVING ALTERNATING HYDROPHILIC AND AMPHIPHILIC POLYMER LAYERS | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2009-12-10 | — | — | WO | disclosed |
| US-20090297575-A1 | Implantable Drug Delivery Devices Having Alternating Hyrdrophilic And Amphiphilic Polymer Layers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137243-A1 | Coating On A Balloon Device | HSPA5, TNNI3, TNNT2 | TSHR 3813/4885LMNA 781/4885ESR1 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.